D-Pharm Ltd.

Samsung Bioepis Co. Ltd. has joined hands with Takeda Pharmaceutical Co. Ltd. to develop novel biologics, moving beyond its core focus on biosimilars. Under the strategic collaboration, the two

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy transactions that occurred between Jan. 9-24. Deal Watc

SHANGHAI - Shanghai Fosun Pharmaceutical Group Co. Ltd. , the Hong Kong-listed pharmaceutical arm of Fosun Group, is set to optimize its financing structure and has completed the issuance of the fi

As the third quarter earnings season starts to trail off, investors could be forgiven for wondering what it takes anymore for the share prices of companies to go up, rather than down. Over the past tw